Peptide-drug Conjugate Information
General Information of This Peptide-drug Conjugate (PDC)
| PDC ID |
PDC_02123
|
|||||
|---|---|---|---|---|---|---|
| PDC Name |
Gefitinib LARLLT conjugate d
|
|||||
| PDC Status |
Investigative
|
|||||
| Structure |
|
|||||
| Peptide Name |
D4
|
Peptide Info | ||||
| Receptor Name |
Pro-epidermal growth factor (EGF)
|
Receptor Info | ||||
| Drug Name |
Gefitinib
|
Drug Info | ||||
| Therapeutic Target |
Epidermal growth factor receptor (EGFR)
|
Target Info | ||||
| Linker Name |
Pimelic acid
|
Linker Info | ||||
| Formula |
C60H92ClFN14O12
|
|||||
| #Ro5 Violations (Lipinski): 4 | Molecular Weight | 1255.933 | ||||
| Lipid-water partition coefficient (xlogp) | 3.6241 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 11 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 16 | |||||
| Rotatable Bond Count (rotbonds) | 38 | |||||